Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-13-000509
Filing Date
2013-05-03
Accepted
2013-05-03 19:28:53
Documents
2
Period of Report
2013-05-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 3997
2 POA sdavis050113form4pa.htm EX-24 10065
  Complete submission text file 0000904454-13-000509.txt   15532
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NEUROGEN CORP 35 NORTHEAST INDUSTRIAL RD BRANFORD CT 06405
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 13814178